NASA Launches Advanced Tissue Research to the International Space Station
SpaceX CRS-35 mission delivers critical experiments for brain, heart, and retinal health studies.
1Mission Launch and Cargo
On October 13, 2026, the SpaceX Dragon spacecraft launched the 35th commercial resupply mission for NASA. The vessel carried over 6,300 pounds of cargo, successfully docking at the International Space Station on October 15. This mission facilitates critical scientific experiments designed to investigate human health in microgravity environments for future space exploration.
2Brain Organoid Research
The AVATAR-ORg1 experiment utilizes lab-grown brain models, known as miBrains, to monitor tissue changes over five weeks. By comparing these space-grown samples with Earth-based controls, researchers aim to identify potential health risks for astronauts. This study provides essential data on how brain tissue develops and functions during long-duration space flight missions.
3Neurodegenerative Disease Studies
The MINDS experiment employs organoid villages, which integrate cells from diverse patient populations to study neurodegenerative conditions. Scientists are specifically investigating the link between inflammation and diseases like Alzheimer's, Parkinson's, and multiple sclerosis. This research seeks to uncover novel treatment pathways by observing cellular behavior in the unique environment of space.
4Heart Tissue Experiments
The Stellar Spheroids experiment focuses on 3D human heart tissue models to analyze the effects of microgravity on cardiac growth and function. By studying these models, scientists intend to improve drug testing protocols and disease research. These findings are vital for ensuring astronaut safety and developing advanced cardiac therapies for Earth-based patients.
5Artificial Retina Development
LambdaVision-1 tests the production of artificial retinas in microgravity to restore sight for those with degenerative diseases. On Earth, gravity causes inconsistencies in the bacteriorhodopsin layers of these retinas. Space-based manufacturing aims to create more uniform, stable layers, potentially overcoming current production limitations that hinder the effectiveness of these light-activated protein devices.
6In-Situ Medical Analysis
The ELISA MABL experiment introduces a compact microplate reader to the station, allowing astronauts to analyze biological samples directly in orbit. This technology detects antibodies, antigens, and proteins, enabling real-time monitoring of health issues like bone density loss. This shift reduces reliance on Earth-bound analysis, significantly improving medical response times for astronauts.
7Antibiotic Resistance Research
The GEARS experiment investigates antibiotic-resistant bacteria, specifically Enterococcus faecalis and Enterococcus faecium, found aboard the station. By studying how these pathogens develop in enclosed microgravity environments, researchers aim to protect crew health. Understanding these bacterial adaptations is crucial for preventing infections during future long-duration missions and enhancing overall space station safety.
8Scientific and Clinical Impact
These diverse experiments represent a significant step toward advancing medical science both in space and on Earth. By leveraging microgravity, NASA is addressing complex biological challenges ranging from neurodegeneration to vision restoration. The data gathered from these projects will inform future mission protocols and potentially yield breakthrough medical treatments for global populations.